Kimiara is a leading pharmaceutical company that has been operating since 2005 as a subsidiary of Ahran Tejarat Group. With a strong focus on importing specialized medicines, Kimiara represents renowned pharmaceutical companies worldwide. Over the years, the company has expanded its scope by venturing into the supply of APIs (Active Pharmaceutical Ingredients) required by manufacturers.

Today, Kimiara ranks among the top 5 companies in the field of API supply. Building on its success, Kimiara has diversified its activities to include the production of specialized medicines and food supplements. By leveraging cutting-edge technology and national manufacturing support policies, the company is known for manufacturing high-quality, bioequivalent products that match the standards set by originators worldwide.

Kimiara's manufacturing operations take place in the state-of-the-art Anidarman factories belonging to Ahran tejarat pharmaceutical group. These facilities boast advanced machinery and manufacturing lines that adhere to international standards and are approved by the Food and Drug Administration. With various departments dedicated to supply and procurement, business development, sales and marketing, regulatory affairs, and financial management, Kimiara ensures a coordinated and efficient operational structure.

The company's commitment to excellence extends to its after-sales service and customer support for the import of pharmaceutical raw materials (APIs) in the Iranian market. Furthermore, Kimiara's medical department plays a crucial role in ensuring the effectiveness of drugs and providing scientific advice and documentation to healthcare professionals. Acting as the company's medical conscience, this department upholds legal requirements and guidelines while offering medical insights throughout the product life cycle.

Overall, Kimiara stands as a reputable pharmaceutical brand, driven by innovation, quality, and a robust supply chain network. For more information and updates, you can visit their website or follow them on their social media platforms